# Meditoxin® Treatment in Patients With Cervical Dystonia

> **NCT03232320** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 66 (actual)

## Conditions studied

- Dystonia
- Dystonic Disorder

## Interventions

- **DRUG:** Meditoxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03232320
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-06
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-11-05
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03232320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03232320, "Meditoxin® Treatment in Patients With Cervical Dystonia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03232320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*